Top Q3 2011 Healthcare Stocks of This Popular Investment Fund Wall St. Cheat Sheet The Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders. Merck & Co., Inc. (NYSE:MRK): On 6/30/11 Blackrock Advisors LLC ... |
